Osama M. Ahmed

Prof. Osama M. Ahmed

Beni-Suef University, Banī Suwayf, Egypt
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2012 in Journal of Diabetes and its Complications
Verified
Journal Article
Closed access
AMAyman Mahmoud
Ayman Mahmoud
MAMohamed B. Ashour
Mohamed B. Ashour
AAAdel Abdel-Moneim
Adel Abdel-Moneim
Osama M. AhmedOsama M. Ahmed
Osama M. Ahmed

12 October 2007 in International Journal of Developmental Neuroscience
Verified
Journal Article
Closed access
Osama M. AhmedOsama M. Ahmed
Osama M. Ahmed
AEA.W. El‐Gareib
A.W. El‐Gareib
AEA.M. El‐Bakry
A.M. El‐Bakry
SES.M. Abd El‐Tawab
S.M. Abd El‐Tawab
AGAHMED R. G.
AHMED R. G.

1 October 2017 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
Osama M. AhmedOsama M. Ahmed
Osama M. Ahmed
MAMohammed Abdel-Gabbar
Mohammed Abdel-Gabbar
MAMohammed Abdel-Gabbar
Mohammed Abdel-Gabbar
MAManal N Abdel Azeem
Manal N Abdel Azeem

15 August 2021 in Molecules
Verified
Journal Article
Open access
PDF file
AKAbdelwahab Khalil
Abdelwahab Khalil
BEBasem H. Elesawy
Basem H. Elesawy
TATarek Ali
Tarek Ali
Osama M. AhmedOsama M. Ahmed
Osama M. Ahmed
Insects of the order Hymenoptera have a defensive substance that contains many biologically active compounds. Specifically, venom from honeybees (Apis mellifera) contains many enzymes and peptides that are effective against various diseases. Different research papers stated the possibility of using bee venom (a direct bee sting or in an injectable form) in treating several complications; either in vivo or in vitro. Other reports used the active fractions of bee venom clinically or at labratory scale. Many reports and publications have stated that bee venom and its constituents have multiple biological activities including anti-microbial, anti-protozoan, anti-cancer, anti-inflammatory, and anti-arthritic properties. The present review aims to refer to the use of bee venom itself or its fractions in treating several diseases and counteracting drug toxicities as an alternative protocol of therapy. The updated molecular mechanisms of actions of bee venom and its components are discussed in light of the previous updated publications. The review also summarizes the potential of venom loaded on nanoparticles as a drug delivery vehicle and its molecular mechanisms. Finally, the products of bee venom available in markets are also demonstrated.

1 September 2009 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Osama M. AhmedOsama M. Ahmed
Osama M. Ahmed
MMMahmoud A. Mohamed
Mahmoud A. Mohamed
RARasha R. Ahmed
Rasha R. Ahmed
SASayed A. Ahmed
Sayed A. Ahmed

22 June 2020 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
AAAlaa M. Ali
Alaa M. Ali
MAMohammed Abdel-Gabbar
Mohammed Abdel-Gabbar
SASanaa M. Abdel-Twab
Sanaa M. Abdel-Twab
EFEman M. Fahmy
Eman M. Fahmy
HEHossam Ebaid
Hossam Ebaid
Osama M. AhmedOsama M. Ahmed
Osama M. Ahmed
This study is aimed at assessing the antihyperglycemic, antihyperlipidemic, and antioxidant effects ofCitrus reticulata(C. reticulata) fruit peel hydroethanolic extract and two flavonoids, hesperidin and quercetin, in nicotinamide (NA)/streptozotocin- (STZ-) induced type 2 diabetic rats. In addition, GC-MS and HPLC-MS analyses of the extract were performed and the results indicated the presence of multiple flavonoids including hesperidin, quercetin, naringin, and polymethoxylated flavones (nobiletin and tangeretin). To achieve the aim of the study, diabetic rats with NA/STZ-induced T2DM were orally treated withC. reticulatafruit peel hydroethanolic extract, hesperidin, and quercetin at a dose of 100 mg/kg b.w./day for four weeks. The treatments withC. reticulatafruit peel extract, hesperidin, and quercetin significantly ameliorated the impaired oral glucose tolerance; the elevated serum fructosamine level; the diminished serum insulin and C-peptide levels; the altered HOMA-IR, HOMA-IS, and HOMA-βcell function; the decreased liver glycogen content; the increased liver glucose-6-phosphatase and glycogen phosphorylase activities; the deleteriously affected serum lipid profile; the elevated serum AST and ALT activities; and the raised serum creatinine and urea levels in the diabetic rats. The treatments also produced remarkable improvement in the antioxidant defense system manifested by a decrease in the elevated liver lipid peroxidation and an increase in the lowered glutathione content and GPx, GST, and SOD activities. Furthermore, the three treatments enhanced the mRNA expression of GLUT-4 and the insulin receptorβ-subunit, but only quercetin produced a significant increase in the expression of adiponectin in adipose tissue of diabetic rats. In conclusion,C. reticulatafruit peel hydroethanolic extract, hesperidin, and quercetin have potent antidiabetic effects which may be mediated through their insulinotropic effects and insulin-sensitizing actions. In addition, the alleviation of the antioxidant defense system by the extract, hesperidin, and naringin may have an important action to enhance the antidiabetic actions and to improve liver and kidney functions in NA/STZ-induced diabetic rats.